Eminence Capital, LP Haleon PLC Transaction History

Eminence Capital, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$8.01 - $8.64 $209,012 - $225,452	26,094 Added 7.96%	353,717 $2.92 Million
Q1 2024 May 15, 2024	SELL	$8.02 - $8.67 $24.3 Million - $26.3 Million	-3,033,479 Reduced 90.25%	327,623 $2.78 Million
Q4 2023 Feb 14, 2024	BUY	$7.78 - $8.62 $2.54 Million - $2.81 Million	326,321 Added 10.75%	3,361,102 $27.7 Million
Q2 2023 Aug 14, 2023	SELL	$8.04 - $9.0 $1.76 Million - $1.97 Million	-218,742 Reduced 6.72%	3,034,781 $25.4 Million
Q1 2023 May 15, 2023	BUY	$7.57 - $8.37 $240,627 - $266,057	31,787 Added 0.99%	3,253,523 $26.5 Million
Q4 2022 Feb 14, 2023	BUY	$5.96 - $8.06 $19.2 Million - $26 Million	3,221,736 New	3,221,736 $25.8 Million

639

412M

149K

16K

Ticker HLN
Exchange
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 4,617,290,240
Market Cap $44.8B
Description
Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...

Get notified when there are updates to the investment portfolio of Eminence Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Eminence Capital, LP with notifications on news.